BioResearch
Protein Kinase May Trigger Malignant Melanomas
Researchers have found that mitogen-activated protein kinase (MAPK), which is inactive in benign moles, is turned on in early-stage malignant melanomas, where it activates two genes that encode for proteins that stimulate angiogenesis and cancerous growth. More...18 Dec 2002
In Other News
Fibroblast Growth Factor Improves Spatial Learning
Scientists Discover Structure of Pain-Modulating Enzyme
Obstructive Sleep Apnea Linked to Defect in Brain Morphology
Automated System for Microdissection of Cells
Biologists Find Basis for Latent Cytomegalovirus Infection
Kiadis and Biofrontera Team Up to Develop Drugs for Pain
Common Virus Found Associated with Colon Cancer
Nucleostemin Plays Critical Role in Stem Cell Maintenance
Tetramers for Autoimmune Disease Research
Evotec and Prolysis to Focus on Antibiotic Drugs
Researchers Create Mouse Model of Human Retrotransposons
High Leptin Levels Increase Breast Cancer Risk
Cytokine Blocks Immune System's Cancer Defense
Enzyme Inhibitors May Lead to Cancer Drug
Growth Prospects of Generic Drug Manufacturing in Asia
Synthetic DNA Nanocircles Aid Study of Aging in Cells
Primed Stem Cells Become Mature Neurons
Inositol Polyphosphate Regulates Genetic Response to Stress
Potent Metastasis Suppressor Gene Identified
COX-2 Inhibitors Slow Bone Growth and Impede Healing
Genetic Factors Increase Cancer Risk from H pylori
Actin Used to Spread Adenovirus Infection
Aspirin Shown to Inhibit Ovarian Cancer Growth
BioResearch brings the latest research news on the genome, proteome, metabolome, on drug discovery, and therapeutics. Biotech researchers, lab administrators, technologists, drug manufacturers, and suppliers can find the latest research news and information related to their fields of endeavor here.







